These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32468469)

  • 21. Extracellular vesicles as an emerging tool for the early detection of Alzheimer's disease.
    Li TR; Wang XN; Sheng C; Li YX; Li FZ; Sun Y; Han Y
    Mech Ageing Dev; 2019 Dec; 184():111175. PubMed ID: 31678325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics profiling of extracellular vesicle for identification of potential biomarkers in Alzheimer's disease: A comprehensive review.
    Pei J; Palanisamy CP; Jayaraman S; Natarajan PM; Umapathy VR; Roy JR; Thalamati D; Ahalliya RM; Kanniappan GV; Mironescu M
    Ageing Res Rev; 2024 Aug; 99():102359. PubMed ID: 38821418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis.
    Rastogi S; Sharma V; Bharti PS; Rani K; Modi GP; Nikolajeff F; Kumar S
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
    Burnouf T; Agrahari V; Agrahari V
    Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research progress on the role of extracellular vesicles in neurodegenerative diseases.
    Li Z; Wang X; Wang X; Yi X; Wong YK; Wu J; Xie F; Hu D; Wang Q; Wang J; Zhong T
    Transl Neurodegener; 2023 Sep; 12(1):43. PubMed ID: 37697342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes.
    Mustapic M; Eitan E; Werner JK; Berkowitz ST; Lazaropoulos MP; Tran J; Goetzl EJ; Kapogiannis D
    Front Neurosci; 2017; 11():278. PubMed ID: 28588440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin.
    Younas N; Fernandez Flores LC; Hopfner F; Höglinger GU; Zerr I
    Transl Neurodegener; 2022 May; 11(1):28. PubMed ID: 35527262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders.
    Burgelman M; Dujardin P; Vandendriessche C; Vandenbroucke RE
    Front Immunol; 2022; 13():1055050. PubMed ID: 36741417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular vesicles - propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases.
    Vassileff N; Cheng L; Hill AF
    J Cell Sci; 2020 Dec; 133(23):. PubMed ID: 33310868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular vesicles in neurodegenerative diseases.
    Croese T; Furlan R
    Mol Aspects Med; 2018 Apr; 60():52-61. PubMed ID: 29137922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarker Organization in Circulating Extracellular Vesicles: New Applications in Detecting Neurodegenerative Diseases.
    Lim CZJ; Natalia A; Sundah NR; Shao H
    Adv Biosyst; 2020 Dec; 4(12):e1900309. PubMed ID: 32597034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and therapeutic potential of exosomes in Alzheimer's disease.
    Soares Martins T; Trindade D; Vaz M; Campelo I; Almeida M; Trigo G; da Cruz E Silva OAB; Henriques AG
    J Neurochem; 2021 Jan; 156(2):162-181. PubMed ID: 32618370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel regulator in Alzheimer's disease progression: The astrocyte-derived extracellular vesicles.
    Li B; Ma Z; Li Z
    Ageing Res Rev; 2023 Apr; 86():101871. PubMed ID: 36736378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of extracellular vesicles in neurodegenerative diseases.
    Xiao Y; Wang SK; Zhang Y; Rostami A; Kenkare A; Casella G; Yuan ZQ; Li X
    Prog Neurobiol; 2021 Jun; 201():102022. PubMed ID: 33617919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.
    Shaw LM; Korecka M; Clark CM; Lee VM; Trojanowski JQ
    Nat Rev Drug Discov; 2007 Apr; 6(4):295-303. PubMed ID: 17347655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocytes, Platelets, Erythrocytes, and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis.
    Pluta R; Ułamek-Kozioł M
    Adv Exp Med Biol; 2019; 1118():71-82. PubMed ID: 30747418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular Vesicles: Mechanisms in Human Health and Disease.
    Malloci M; Perdomo L; Veerasamy M; Andriantsitohaina R; Simard G; Martínez MC
    Antioxid Redox Signal; 2019 Feb; 30(6):813-856. PubMed ID: 29634347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases.
    Okazawa H
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(6):361-377. PubMed ID: 28603208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer's disease.
    Liew LC; Katsuda T; Gailhouste L; Nakagama H; Ochiya T
    Int Immunol; 2017 Jan; 29(1):11-19. PubMed ID: 28184439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges associated with using extracellular vesicles as biomarkers in neurodegenerative disease.
    Couch Y
    Expert Rev Mol Diagn; 2023; 23(12):1091-1105. PubMed ID: 37916853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.